[A first trial in the clinical study of bonnecor].
The brief data on the results of the clinical trials of a new antiarrhythmic drug bonnecor at intravenous administration performed in six clinical institutions of the country are presented. A high effectiveness and a good tolerance of the drug in VT, VE, ST, SE and WPW syndrome were revealed.